We offer
Telehealth Services
Telehealth is a safe and convenient option to receive care from home. Please contact us to find out more about Telehealth Services for mental health care.
When other forms of therapies have failed to adequately address depression, anxiety or trauma, Ketamine Assisted Psychotherapy (KAP) is an effective and safe alternative that can result in transformational outcomes and lasting change.
While Ketamine has traditionally been used for anesthesia, mental health professionals are increasingly harnessing ketamine’s enormous therapeutic potential to treat depression, trauma, and other mental health conditions.
In the world of mental health treatment, a groundbreaking therapy is emerging that offers new hope for those struggling with persistent psychological challenges. Ketamine Assisted Psychotherapy (KAP) is revolutionizing the way we approach mental health care, providing a unique and powerful tool for healing and personal growth. This treatment that combines the therapeutic potential of ketamine with personalized psychotherapy is gaining recognition for its ability to enhance psychological well-being.
KAP is a therapeutic approach that combines the administration of ketamine, a medication with dissociative and psychedelic effects, with personalized psychotherapy sessions. This innovative treatment has been gaining traction as an alternative for individuals who have found limited success with traditional therapies or medications.
As mental health professionals continue to seek more effective ways to address complex disorders, KAP has emerged as a promising option, offering rapid relief and profound insights for many patients. The growing interest in this therapy reflects a broader shift towards more integrative and holistic approaches to mental health care, including psychedelic therapy.
Ketamine Assisted Psychotherapy represents a fusion of pharmacology and psychotherapy, leveraging the unique properties of ketamine to enhance the therapeutic process. Originally developed as an anesthetic in the 1960s, ketamine’s potential for treating mental health disorders in much lower than anesthetic doses, was discovered in the early 2000s.
Unlike traditional talk therapy or standalone ketamine infusions, KAP creates a synergistic effect by combining the two modalities. The ketamine component induces a temporary altered state of consciousness, often described as a psychedelic experience, which can help break entrenched thought patterns and facilitate deeper emotional processing. Meanwhile, the psychotherapy aspect provides a supportive framework for exploring insights, processing emotions, and integrating the experience.
KAP offers rapid relief from symptoms, often within hours or days. It enhances neuroplasticity, allowing for new perspectives and behaviors. The treatment increases emotional openness and reduces defensive mechanisms, creating a catalytic effect on the therapeutic process and potentially accelerating progress.
This therapeutic intervention works by stimulating new dendritic and synaptic growth between the neurons connecting our mood, potentially leading to long-lasting improvements in mental health.
The efficacy of KAP lies in its multifaceted approach to healing, targeting both neurobiological and psychological aspects of mental health.
At the neurobiological level, ketamine primarily acts on the brain’s glutamate system. It blocks N-methyl-D-aspartate (NMDA) receptors, leading to increased glutamate production. This surge in glutamate triggers a cascade of neuroplastic changes, essentially allowing the brain to form new neural connections and pathways.
To illustrate this process, imagine your brain as a snow-covered field. Traditional thought patterns are like well-worn paths through the snow. Ketamine temporarily “melts” this snow, allowing for the creation of new paths – representing fresh perspectives and behaviors. The psychotherapy component then helps guide the formation of these new, healthier pathways.
Experientially, KAP induces a dissociative state characterized by altered perception of time and space, a sense of detachment from one’s body or sense of self, heightened introspection and emotional awareness, and potential for vivid imagery or symbolism.
These effects, while temporary, can provide a unique vantage point from which to examine one’s thoughts, emotions, and life experiences, often leading to profound insights and breakthroughs.
At Amavi, we’ve developed a comprehensive KAP process designed to maximize therapeutic benefits while ensuring patient safety and comfort. Our approach typically involves:
A thorough assessment of medical history, current symptoms, and treatment goals.
Mental status examination to establish a baseline for treatment.
Education about the KAP process and development of intention-setting strategies.
Discussion of dosage and potential psychedelic experiences.
Carefully monitored dosing in a calm, supportive environment, with the KAP therapist always present in the room with the patient to ensure safety and comfort throughout the session.
Expert facilitation during the ketamine experience to promote insight and emotional processing.
A dedicated time for post-experience reflection, helping the patient process insights and develop practical strategies to incorporate into daily life.
Our clinical team consists of highly trained professionals with extensive experience in both traditional psychotherapy and psychedelic-assisted treatments. This expertise allows us to create a safe, nurturing environment that supports deep healing and transformation.
KAP has shown promising results in treating a variety of mental health conditions, including treatment-resistant depression, post-traumatic stress disorder (PTSD), and anxiety disorders.
Research findings support the efficacy of KAP. A 2006 study found that a single ketamine infusion produced significant antidepressant effects within 2 hours, with effects lasting up to 1 week. A 2013 review of ketamine for PTSD showed promising results, with some patients experiencing symptom relief after a single session.
KAP may be suitable for individuals who have not responded adequately to traditional treatments, are seeking a more rapid or intensive approach to therapy, or are open to exploring altered states of consciousness as part of their healing process.
However, KAP is not appropriate for everyone. Some of the contraindications include active psychosis or schizophrenia, severe cardiovascular disease, untreated hypertension, and pregnancy or breastfeeding.
To determine if KAP is right for you, consider scheduling a consultation with a qualified provider who can assess your individual needs and medical history.
Proper preparation is key to a beneficial KAP experience. Some of our recommendations include setting clear intentions for your session, practicing relaxation techniques, avoiding heavy meals, alcohol, and recreational drugs for 24 hours prior to treatment. It is necessary to arrange for transportation home after the session.
During your preparation session, your therapist will provide detailed guidance and answer any questions you may have about the process.
In KAP, the therapist plays a crucial role in guiding and supporting the patient throughout the experience. Our therapists are trained in creating a safe and supportive environment, facilitating emotional processing and insight generation, providing grounding techniques if needed, and helping patients integrate their experiences into everyday life.
Therapists use a variety of techniques, including mindfulness practices, somatic experiencing, and cognitive-behavioral approaches, to tailor the experience to each individual’s needs and goals.
Many patients have found KAP to be a transformative experience. Sarah, a 35-year-old woman who had struggled with depression for over a decade, and tried 3 different antidepressants with limited effect, and John, a 46 year-old man who had been dealing with PTSD from chronic trauma as a child, both reported significant improvements in their conditions and overall quality of life after undergoing KAP.
When administered by trained professionals in a controlled setting, KAP has a strong safety profile. However, as with any medical treatment, there are potential risks and side effects that will be thoroughly discussed during your consultation.
We typically recommend starting with a 6-session series, after which we create a personalized plan that may include ongoing maintenance sessions tailored to each individual’s needs.
Currently, most insurance plans do not cover KAP. However, we offer various payment options and can provide documentation for out-of-network reimbursement if applicable.
The journey of ketamine from anesthetic to revolutionary mental health treatment is a fascinating one. Developed in the 1960s as a safer alternative to phencyclidine (PCP), ketamine was initially used as a battlefield anesthetic during the Vietnam War. Its rapid onset and relatively short duration made it ideal for emergency situations.
In the 1990s, researchers began to notice ketamine’s mood-altering effects. A groundbreaking study in 2000 by Berman et al. demonstrated ketamine’s rapid antidepressant effects, sparking intense interest in its potential for treating mood disorders.
The development of Ketamine Assisted Psychotherapy represents the next evolution in this journey. By combining ketamine’s neurobiological effects with targeted psychotherapy, practitioners found they could enhance and extend the benefits of ketamine treatment.
Ketamine’s impact on the brain is complex and multifaceted, involving several interconnected neurobiological mechanisms. At its core, ketamine’s primary action involves blocking N-methyl-D-aspartate (NMDA) receptors, but this initiates a cascade of neurochemical and neuroplastic changes that contribute to its unique therapeutic effects.
When ketamine blocks NMDA receptors, it leads to an increase in glutamate transmission. Glutamate is the brain’s primary excitatory neurotransmitter, playing a crucial role in learning, memory, and neuroplasticity. This surge in glutamate activates α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors. The activation of AMPA receptors is a critical step in ketamine’s antidepressant effects, as it triggers several downstream processes.
One of the key consequences of AMPA receptor activation is the increased release of brain-derived neurotrophic factor (BDNF). BDNF is a protein that plays a vital role in neuroplasticity – the brain’s ability to form new neural connections and adapt. It promotes the growth and differentiation of new neurons and synapses, a process known as synaptogenesis. This enhanced neuroplasticity is thought to be a fundamental mechanism by which ketamine can rapidly alleviate depressive symptoms and promote long-term changes in brain function.
Ketamine also appears to influence the mammalian target of rapamycin (mTOR) signaling pathway. The mTOR pathway is involved in cell growth, proliferation, and survival. In the context of mental health, mTOR activation has been linked to increased synaptic protein synthesis and the formation of new dendritic spines – tiny protrusions on neurons that receive input from other neurons. This process of synapse formation and strengthening is believed to contribute to the rapid and sustained antidepressant effects observed with ketamine treatment.
From a broader brain network perspective, ketamine’s dissociative effects can be understood as a temporary disruption of default mode network (DMN) activity. The DMN is a collection of brain regions that are active when we’re engaged in self-referential thinking, such as rumination or mind-wandering. In depression and anxiety, the DMN is often overactive, contributing to negative self-focused thoughts and worry.
By disrupting DMN activity, ketamine may provide a temporary “reset” of these patterns, allowing for new perspectives and increased cognitive flexibility. This disruption may explain the sense of detachment from one’s usual thought patterns that many people experience during ketamine sessions, as well as the potential for novel insights and shifts in perspective.
While ketamine’s primary action is on the glutamate system, it also indirectly affects other neurotransmitter systems. For instance, it can lead to increased dopamine release in certain brain regions, which may contribute to its mood-elevating and motivational effects. Additionally, ketamine has been shown to have anti-inflammatory effects in the brain, which is significant given the growing understanding of the role of neuroinflammation in depression and other mental health disorders.
One of the most striking aspects of ketamine’s neurobiology is the rapidity of its effects. Unlike traditional antidepressants, which typically take weeks to show benefit, ketamine can produce noticeable improvements in mood within hours. This rapid onset is thought to be due to the immediate impact on glutamate transmission and the quick activation of neuroplasticity mechanisms.
Moreover, the neuroplastic changes initiated by ketamine can persist beyond the acute effects of the drug itself. This may explain why a single ketamine session can sometimes produce sustained benefits lasting days or even weeks. The psychotherapy component of KAP aims to capitalize on this window of enhanced neuroplasticity, helping to consolidate positive changes and translate insights into lasting behavioral and emotional shifts.
Understanding the neuroscience behind KAP not only helps explain its efficacy but also points the way to future research and refinements in treatment protocols. As our knowledge of these mechanisms deepens, we may be able to develop even more targeted and effective approaches to mental health treatment.
While the immediate effects of ketamine can be profound, the true power of KAP lies in the integration process. Integration refers to the ongoing work of incorporating insights and experiences from KAP sessions into daily life.
At Amavi, we place great emphasis on integration support. This typically involves immediate post-session processing, follow-up therapy sessions, lifestyle modifications, and ongoing therapeutic practices.
Effective integration can help extend the benefits of KAP well beyond the immediate effects of the ketamine, leading to sustained improvements in mood, behavior, and overall well-being.
As research into KAP continues to grow, we’re seeing exciting developments on the horizon. Areas of ongoing investigation include optimal dosing protocols, combination therapies, biomarker identification, long-term outcomes, and expanded applications.
As the field of psychedelic-assisted therapies continues to evolve, KAP is likely to play a significant role in shaping the future of mental health treatment. Its rapid effects, potential for deep psychological insight, and ability to catalyze neuroplasticity make it a powerful tool in the ongoing effort to address the global mental health crisis.
At Amavi, we’re committed to staying at the forefront of these developments, continually refining our approach to provide the most effective, evidence-based care possible. We believe that KAP, when administered responsibly and integrated thoughtfully, has the potential to transform lives and offer new hope to those who have long struggled with mental health challenges.
As we look to the future, we invite you to join us on this journey of exploration and healing. Whether you’re considering KAP for yourself or simply curious about new frontiers in mental health treatment, we’re here to provide information, support, and compassionate care. Together, we can work towards a future where true healing is not just possible, but accessible to all who seek it.
Telehealth is a safe and convenient option to receive care from home. Please contact us to find out more about Telehealth Services for mental health care.